University of Oxford/AstraZeneca
|
Non-Replicating Viral Vector
|
ChAdOx1-S
(AZD1222)
|
2 doses at day 0 and 28
|
NCT04516746
|
February 2023
|
|
|
|
|
ISRCTN89951424 |
December 2021 |
|
|
|
|
NCT04540393 |
March 2021 |
|
|
|
|
CTRI/2020/08/027170 |
March 2021* |
Moderna/NIAID |
RNA |
LNP-encapsulated mRNA (mRNA-1273) |
2 doses at day
0 and 28 |
NCT04470427 |
October 2022 |
BioNTech/Fosun Pharma/Pfizer |
RNA |
3 LNP-mRNAs (BNT162b2) |
2 doses at
day 0 and 21 |
NCT04368728 |
January 2023 |
Janssen Pharmaceutical Companies (Johnson & Johnson) |
Non-Replicating
Viral Vector |
Adenovirus Type 26 vector (Ad26.COV2.S) |
1 dose at day 0 |
NCT04505722 |
March 2023 |
|
|
|
|
ISRCTN14722499 |
May 2023 |
|
|
|
2 doses at day 0 and 56 |
|
|
Novavax
|
Protein Subunit
|
Full length recombinant SARS CoV-2 glycoprotein nanoparticle vaccine
adjuvanted with Matrix M
(SARS-CoV-2 rS/Matrix-M1 Adjuvant)
|
2 doses at day
0 and 21
|
2020-004123-16
|
September 2021*
|
|
|
|
|
NCT04611802 |
December 2022 |
Sinovac
|
Inactivated
|
Inactivated (CoronaVac)
|
2 doses at day
0 and 14
|
NCT04456595
|
October 2021
|
|
|
|
|
669/UN6.KEP/EC/2020 |
Not reported |
|
|
|
|
NCT04582344 |
April 2021 |
|
|
|
|
NCT04617483 |
May 2021 |
Wuhan Institute of Biological Products/Sinopharm
|
Inactivated
|
Inactivated
|
2 doses at day
0 and 21
|
ChiCTR2000034780
|
July 2021
|
|
|
|
|
ChiCTR2000039000 |
December 2020 |
|
|
|
|
NCT04612972 |
September 2021 |
Beijing Institute of Biological Products/Sinopharm
|
Inactivated
|
Inactivated
|
2 doses at day
0 and 21
|
ChiCTR2000034780
|
July 2021
|
|
|
|
|
NCT04560881 |
December 2021 |
Bharat Biotech
|
Inactivated
|
Whole-Virion Inactivated
|
2 doses at day
0 and 28
|
CTRI/2020/11/028976
|
November 2021*
|
|
|
|
|
NCT04641481 |
March 2022 |
CanSino Biological Inc./Beijing Institute of Biotechnology |
Non-Replicating Viral Vector |
Adenovirus Type 5 Vector |
1 dose |
NCT04526990 |
January 2022 |
|
|
|
|
NCT04540419 |
July 2021 |
Gamaleya Research Institute
|
Non-Replicating Viral Vector
|
Adeno-based (rAd26-S+rAd5-S, Sputnik V)
|
2 doses at day
0 and 21
|
NCT04530396
|
May 2021
|
|
|
|
|
NCT04564716 |
April 2021 |
|
|
|
|
NCT04642339 |
December 2021 |
Anhui Zhifei Longcom Biopharmaceutical/Institute of Microbiology,
Chinese Academy of Sciences
|
Protein Subunit
|
Adjuvanted recombinant protein (RBD-Dimer) expressed in CHO cells
|
3 doses at day
0, 28, and 56
|
ChiCTR2000040153
|
December 2021
|
Medicago Inc.
|
VLP
|
Plant-derived VLP adjuvanted with AS03
|
2 doses at day
0 and 21
|
NCT04636697
|
April 2022
|